000			04008cam a2200421Ii 4500
988			_aSpringer_Medicine_2017
999			_c96464 _d96464 _x1
001			96464
003			ES-MaUEC
005			20230102112755.0
006			m o d
007			cr cnu|||unuuu
008			170901s2017 ja a ob 000 0 eng d
020			_a4431551336 _q(electronic bk.)
020			_a9784431551331 _q(electronic bk.)
020			_z4431551328
020			_z9784431551324
040			_aN$T _beng _erda _epn _cN$T _dDKU _dN$T _dGW5XE _dYDX _dUAB _dNJR _dAZU _dUPM _dMERER _dOCLCQ _dESU _dIOG _dCOO _dES-MaUEC _bspa
050		4	_aRC78.7.D53 _b2017 EB
245	0	0	_aNeuroimaging diagnosis for alzheimer's disease and other dementias _cHiroshi Matsuda, Takashi Asada, Aya Midori Tokumaru, editors.
264		1	_aTokyo, Japan _bSpringer International Publishing _c2017
300			_a1 recurso en línea _bilustraciones (algunas a color)
336			_aTexto _btxt _2rdacontent
337			_aelectrónico _bc _2rdamedia
338			_arecurso electrónico _bcr _2rdacarrier
347			_atext file _bPDF
500			_a
504			_aIncluye referencias bibliográficas
505	0		_a1 -- Epidemiology of dementia in Japan 2 -- Diagnostic criteria for Alzheimer's disease 3 -- Pathology for Alzheimer's disease and other dementias 4 -- Structural neuroimaging in Alzheimer's disease 5 -- MRI diagnosis in other dementias 6 -- Diffusion Tensor Imaging in dementia 7 -- Arterial Spin Labeling in dementia 8 -- Magnetic Resonance Spectroscopy in dementia 9 -- Resting-state fMRI in dementia 10 -- FDG-PET in Alzheimer's disease 11 -- Amyloid PET in Alzheimer's disease 12 -- Tau PET in neurodegenerative diseases manifesting dementia 13 -- Bran perfusion SPECT in Alzheimer's disease 14 -- Neuroimaging of dementia with Lewy bodies 15 -- Neuroimaging of frontotemporal lobe degeneration 16 -- Neuroimaging study of Alzheimer's disease in population-based cohort 17 -- Handling of MRI data in a multi-center study 18 -- Standardization and quality control of PET data in a multi-center study.
520	3		_aThis book describes the latest modalities such as tau PET imaging for diagnosis of Alzheimer's disease and other dementias, and also provides information on handling and analyzing imaging data that is not found in other books. In addition, it introduces routine imaging studies in the management of dementia in Japan. The prevalence of dementia has increased over the past few decades, either because of greater awareness and more accurate diagnosis, or because increased longevity has created a larger population of the elderly, the age group most commonly affected. Although only clinical assessment can lead to a diagnosis of dementia, neuroimaging in dementia is recommended by most clinical guidelines, and its adjunct role has traditionally been to exclude a mass lesion rather than to support a specific diagnosis. Neuroimaging may be also helpful for developing new strategies to achieve diagnoses as early as possible for therapies aimed at slowing the progression of neurodegenerative diseases manifesting dementia. Under these conditions, all clinicians and researchers who are involved in neuroimaging for dementia should decide which patients to scan, when imaging patients is most useful, which modality to use, how to handle imaging data from many institutions, and which analytical tool to use. This edition comprises contributions from leading Japanese experts in their fields.
588	0		_aOnline resource; title from PDF title page (EBSCO, viewed September 13, 2017).
650		7	_2embne _aDiagnóstico por imagen _9139972
700	1		_aAsada, Takashi, _eeditor literario
700	1		_aMatsuda, Hiroshi, _eeditor literario
700	1		_aTokumaru, Aya Midori, _eeditor literario
856	4	0	_uhttps://go.openathens.net/redirector/universidadeuropea.es?url=http://link.springer.com/10.1007/978-4-431-55133-1 _zAcceso a este recurso digital (usuarios Universidad Europea de Madrid)
942			_2lcc _cLE
998			_b02/2018 _dz _e- _zSI